Beyond weight loss and glucose control, how do you see GLP-1 agonists being leveraged to treat other conditions, such as cardiovascular disease, chronic kidney disease, sleep apnea, or osteoarthritis
This event brings together leading physicians, researchers, and wellness experts focused on aging, cellular health, and regenerative science
Those who were prescribed this drug and were overweight or had obesity were more than seven times more likely to get the diagnosis
Side effects are typically mild, temporary, and manageable
O.GibalaM
No, as long as you maintain proper spacing